Designing new drugs is a complex, multi-objective problem, requiring the simultaneous optimisation of target affinity, target tissue exposure, formulation, toxicity – the list goes on. Innovative drug designers are constantly identifying new methods they can use to improve their drug design capabilities to the extent that designers now have unprecedented access to data, tools and resources. The challenge faced by many is how to integrate these multiple inputs and opinions to maximise their effect and accelerate drug discovery projects into the clinic.
27 June, 2013
The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.
10 June, 2013